| Primary |
| Product Used For Unknown Indication |
46.1% |
| Depression |
28.9% |
| Pustular Psoriasis |
3.3% |
| Antiemetic Supportive Care |
2.2% |
| Anxiety Disorder |
2.2% |
| Headache |
2.2% |
| Suicide Attempt |
2.2% |
| General Anaesthesia |
1.7% |
| Aspergillus Infection |
1.1% |
| Back Pain |
1.1% |
| Contraception |
1.1% |
| Depressed Mood |
1.1% |
| Depressive Symptom |
1.1% |
| Generalised Anxiety Disorder |
1.1% |
| Maintenance Of Anaesthesia |
1.1% |
| Schizophrenia |
1.1% |
| Aggression |
0.6% |
| Arthralgia |
0.6% |
| Asthma |
0.6% |
| Atrial Fibrillation |
0.6% |
|
| Toxicity To Various Agents |
23.0% |
| Unresponsive To Stimuli |
8.2% |
| Completed Suicide |
6.6% |
| Pustular Psoriasis |
6.6% |
| Tremor |
6.6% |
| Vomiting |
4.9% |
| Extrapyramidal Disorder |
3.3% |
| Gastric Cancer Stage Iv |
3.3% |
| Gastroenteritis Viral |
3.3% |
| Intentional Self-injury |
3.3% |
| Loss Of Libido |
3.3% |
| Major Depression |
3.3% |
| Muscular Weakness |
3.3% |
| Nausea |
3.3% |
| Psychotic Disorder |
3.3% |
| Restless Legs Syndrome |
3.3% |
| Ventricular Fibrillation |
3.3% |
| Viith Nerve Paralysis |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
| Anaphylactic Reaction |
1.6% |
|
| Secondary |
| Product Used For Unknown Indication |
77.2% |
| Depression |
8.7% |
| Schizophrenia, Paranoid Type |
3.9% |
| Cardiac Disorder |
3.1% |
| Bipolar Disorder |
0.8% |
| Chest Pain |
0.8% |
| Convulsion |
0.8% |
| Diabetes Mellitus |
0.8% |
| Fibromyalgia |
0.8% |
| Gastrointestinal Disorder |
0.8% |
| Intraoperative Care |
0.8% |
| Smoking Cessation Therapy |
0.8% |
| Vasoplegia Syndrome |
0.8% |
|
| Toxicity To Various Agents |
23.3% |
| Drug Abuse |
6.7% |
| Myalgia |
6.7% |
| Overdose |
6.7% |
| Serotonin Syndrome |
6.7% |
| Completed Suicide |
3.3% |
| Convulsion |
3.3% |
| Death |
3.3% |
| Exposure Via Ingestion |
3.3% |
| Myositis |
3.3% |
| Oedema Peripheral |
3.3% |
| Poisoning |
3.3% |
| Psychotic Disorder |
3.3% |
| Respiratory Arrest |
3.3% |
| Self-medication |
3.3% |
| Suicide Attempt |
3.3% |
| Tachycardia |
3.3% |
| Tremor |
3.3% |
| Urticaria |
3.3% |
| Vasoplegia Syndrome |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.1% |
| Multiple Sclerosis |
10.6% |
| Osteoporosis |
9.6% |
| Bipolar Disorder |
7.4% |
| Drug Use For Unknown Indication |
6.4% |
| Hypertension |
6.4% |
| Anxiety |
4.3% |
| Plasma Cell Myeloma |
4.3% |
| Blood Cholesterol Increased |
3.2% |
| Cardiac Disorder |
3.2% |
| Depression |
3.2% |
| Intentional Overdose |
3.2% |
| Osteoporosis Prophylaxis |
3.2% |
| Type 2 Diabetes Mellitus |
3.2% |
| Blood Pressure Abnormal |
2.1% |
| Cholesterol High |
2.1% |
| Hypomania |
2.1% |
| Myelodysplastic Syndrome |
2.1% |
| Nephrogenic Anaemia |
2.1% |
| Peripheral Nerve Injury |
2.1% |
|
| Hypomagnesaemia |
7.3% |
| Urinary Tract Infection |
7.3% |
| Vision Blurred |
7.3% |
| Vomiting |
7.3% |
| Weight Increased |
7.3% |
| Migraine |
4.9% |
| Pancreatitis |
4.9% |
| Personality Change |
4.9% |
| Sickle Cell Anaemia With Crisis |
4.9% |
| Swelling Face |
4.9% |
| Syncope |
4.9% |
| Tachycardia |
4.9% |
| Tremor |
4.9% |
| Urticaria |
4.9% |
| White Blood Cell Count Decreased |
4.9% |
| Withdrawal Syndrome |
4.9% |
| Anaphylactic Reaction |
2.4% |
| Aneurysm |
2.4% |
| Aphasia |
2.4% |
| Dizziness |
2.4% |
|
